Simon Read - 22 May 2025 Form 3 Insider Report for Dianthus Therapeutics, Inc. /DE/ (DNTH)

Role
Director
Signature
/s/ Adam Veness, as attorney-in-fact for Simon Read
Issuer symbol
DNTH
Transactions as of
22 May 2025
Net transactions value
$0
Form type
3
Filing time
22 May 2025, 16:39:18 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Read Simon Director C/O DIANTHUS THERAPEUTICS, INC., 7 TIMES SQUARE, 43RD FLOOR, NEW YORK /s/ Adam Veness, as attorney-in-fact for Simon Read 22 May 2025 0001688199

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney